January 16, 2018 : DCMS #380

DISASTERS AVERTED — Near Miss Case Studies

A Way to Motivate Unmotivated Patients

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Ray Kausik Part 3, PCSK9 Effect On Lowering Cardiovascular Death

HOMERUN SLIDES — Great Clinical Presentation Highlights

Framework for Understanding DM Part 4

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #108: Type 2 Diabetes and Cancer Part 1

MOST POPULAR ARTICLES OF THE MONTH

#1 A Better Way to Diagnose and Treat Patients Than Doctors?
#2 A Summary of ADA’s New 2018 Standards of Medical Care in Diabetes
#3 Why Are We Waiting To Treat Diabetes Until A1c Reaches 6.5%?

So often in patients with diabetes, there are multiple co-morbidities that can lead to premature death or at the least a decreased quality of life. There is often the question as to which disease comes first and whether the combination of these diseases worsen each other. This week, our Clinical Text looks into these questions, starting with the relationship between diabetes and cancer.

Dave Joffe

Editor-in-chief

Young man, 21 years of age. type 1 diabetes since 9 years of age. Has not been to see hcp for a year. States he doesn’t like people interrogating him, but came in because he needs his insulin. States he doesn’t check his glucose because he can tell what it is. Tired of having type 1 diabetes and tired of checking numbers. A1C in office–10.2%.

In part 3 of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, CA about work toward lowering the risk of cardiovascular death.

In this week’s Homerun Slides, the genetics of diabetes and the implications for beta cells.

Introduction: An association between hyperglycemia, diabetes, and cancer has been recognized for many years. Epidemiologists first noted the association between diabetes and cancer in the early part of the twentieth century, while the association between hyperglycemia and cancer was reported in 1885. At that time, in Europe and North America life expectancy was improving, rates of over-nutrition and under-exercise were increasing, there was a rise in the percentage of people that were overweight, and the incidence of diabetes began to climb.

With millions of possible drug combinations for treatment of diabetes, hypertension, hyperlipidemia and heart disease, new AI program offers more thorough analysis and options.

Comprehensive recommendations feature notable new recommendations for people with cardiovascular disease and diabetes.

Getting type 2 diabetes at an early age increases risk for all diabetes complications, including death.